Adenocarcinomas of the lower oesophagus and gastro-oesophageal junction are a complex clinico-pathological setting. Multimodality therapy is considered mandatory in most disease presentations. Nevertheless, the most appropriate treatment package has yet to be established. We herein summarize the evidence derived from randomized phase III trials on pre-operative treatments in this oncological scenario.
Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials
FRANCO, Pierfrancesco
First
;ARCADIPANE, FRANCESCA;STRIGNANO, Paolo;SPADI, ROSELLA;TRINO, Elisabetta;MARTINI, STEFANIA;IORIO, GIUSEPPE CARLO;SATOLLI, MARIA ANTONIETTA;AIROLDI, Mario;ROMAGNOLI, Renato;CAMANDONA, Michele;RICARDI, Umberto
Last
2017-01-01
Abstract
Adenocarcinomas of the lower oesophagus and gastro-oesophageal junction are a complex clinico-pathological setting. Multimodality therapy is considered mandatory in most disease presentations. Nevertheless, the most appropriate treatment package has yet to be established. We herein summarize the evidence derived from randomized phase III trials on pre-operative treatments in this oncological scenario.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
definitive.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
388.33 kB
Formato
Adobe PDF
|
388.33 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
